{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:46:22Z","timestamp":1768416382904,"version":"3.49.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:00:00Z","timestamp":1544486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery Case Reports"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.ijscr.2018.11.065","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T21:36:05Z","timestamp":1544564165000},"page":"108-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Intraperitoneal doxorubicin achieves access to mesenteric lymph nodes, case series of two patients"],"prefix":"10.1097","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2431-7366","authenticated-orcid":false,"given":"Paul H.","family":"Sugarbaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. Anthony","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijscr.2018.11.065_bib0005","series-title":"Peritoneal Carcinomatosis: Principles of Management","first-page":"415","article-title":"A simplified approach to hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) using a self retaining retractor","author":"Sugarbaker","year":"1996"},{"issue":"3","key":"10.1016\/j.ijscr.2018.11.065_bib0010","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1055-3207(03)00038-3","article-title":"Intraperitoneal taxanes","volume":"12","author":"Mohamed","year":"2003","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"10.1016\/j.ijscr.2018.11.065_bib0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00280-010-1460-4","article-title":"Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis","volume":"68","author":"Van der Speeten","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijscr.2018.11.065_bib0020","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jso.21702","article-title":"Pharmacology of perioperative 5-fluorouracil","volume":"102","author":"Van der Speeten","year":"2010","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.ijscr.2018.11.065_bib0025","first-page":"9","article-title":"Pharmacokinetic study of perioperative intravenous ifosfamide","volume":"185092","author":"Van der Speeten","year":"2011","journal-title":"Int. J. Surg. Oncol."},{"key":"10.1016\/j.ijscr.2018.11.065_bib0030","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ejso.2011.04.007","article-title":"Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis","volume":"37","author":"Sugarbaker","year":"2011","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ijscr.2018.11.065_bib0035","article-title":"Intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer, rationale and report of early data","volume":"2011","author":"Sugarbaker","year":"2011","journal-title":"Int. J. Surg. Oncol."},{"key":"10.1016\/j.ijscr.2018.11.065_bib0040","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/827534","article-title":"Hyperthermic intraperitoneal chemotherapy with melphalan: a summary of clinical and pharmacologic data in 34 patients","volume":"2012","author":"Bijelic","year":"2012","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.ijscr.2018.11.065_bib0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijsu.2016.10.025","article-title":"The PROCESS statement: preferred reporting of case series in surgery","volume":"36","author":"Agha","year":"2016","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ijscr.2018.11.065_bib0050","series-title":"Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas","first-page":"47","article-title":"Cancer chemotherapy for peritoneal metastases: pharmacology and treatment","author":"Van der Speeten","year":"2017"},{"key":"10.1016\/j.ijscr.2018.11.065_bib0055","series-title":"Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas","first-page":"17","article-title":"An overview of peritonectomy, visceral resection, and therapeutic laparoscopy for peritoneal surface malignancy","author":"Sugarbaker","year":"2017"},{"issue":"9","key":"10.1016\/j.ijscr.2018.11.065_bib0060","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ejso.2006.05.009","article-title":"Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma","volume":"32","author":"Yan","year":"2006","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ijscr.2018.11.065_bib0065","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/ejso.2000.0983","article-title":"Multitargeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model","volume":"26","author":"Pestieau","year":"2000","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ijscr.2018.11.065_bib0070","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jss.2008.06.049","article-title":"Different tissue distribution of paclitaxel with intravenous and intraperitoneal administration","volume":"155","author":"Soma","year":"2009","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ijscr.2018.11.065_bib0075","first-page":"3209","article-title":"Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer","volume":"39","author":"Ozols","year":"1979","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ijscr.2018.11.065_bib0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s002800050721","article-title":"Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model","volume":"41","author":"Jacquet","year":"1998","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijscr.2018.11.065_bib0085","series-title":"Lymph Flow from the Peritoneal Cavity in CAPD Patients. Frontiers in Peritoneal Dialysis","first-page":"24","author":"Rippe","year":"1986"},{"key":"10.1016\/j.ijscr.2018.11.065_bib0090","first-page":"1916","article-title":"Portal levels and hepatic clearance of 5 fluorouracil after intraperitoneal administration in humans","volume":"41","author":"Speyer","year":"1981","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ijscr.2018.11.065_bib0095","first-page":"29","article-title":"Surgical technology and pharmacology of hyperthermic perioperative chemotherapy","volume":"7","author":"Sugarbaker","year":"2016","journal-title":"J. Gastrointest. Oncol."},{"issue":"1","key":"10.1016\/j.ijscr.2018.11.065_bib0100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Gynecologic oncology group. Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261218305741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261218305741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:41:03Z","timestamp":1768387263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210261218305741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":20,"alternative-id":["S2210261218305741"],"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2018.11.065","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraperitoneal doxorubicin achieves access to mesenteric lymph nodes, case series of two patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijscr.2018.11.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.","name":"copyright","label":"Copyright"}]}}